Literature DB >> 25362541

Vestibular schwannoma in a patient with neurofibromatosis type 1: clinical report and literature review.

Aamira Huq1, Maira Kentwell, Amanda Tirimacco, Jacqueline Rossini, Lesley Rawlings, Ingrid Winship.   

Abstract

We describe a young patient with typical neurofibromatosis type 1 on the basis of a mutation in the NF1 gene, who was diagnosed with a unilateral vestibular schwannoma caused by a somatic mutation in the NF2 gene. This combination has not been described before. This report highlights the requirement for ongoing surveillance regarding other manifestations of neurofibromatosis type 2 in such patients, as mosaicism cannot be ruled out. In addition to the NF1 mutation, the NF2 mutation should be considered in such cases if pre-implantation genetic diagnosis in undertaken.

Entities:  

Mesh:

Year:  2015        PMID: 25362541     DOI: 10.1007/s10689-014-9763-y

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  19 in total

1.  Preimplantation genetic diagnosis for neurofibromatosis type 1.

Authors:  C Spits; M De Rycke; N Van Ranst; H Joris; W Verpoest; W Lissens; P Devroey; A Van Steirteghem; I Liebaers; K Sermon
Journal:  Mol Hum Reprod       Date:  2005-04-15       Impact factor: 4.025

2.  Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.

Authors:  Manish Aghi; Lan Kluwe; Micah T Webster; Lee B Jacoby; Fred G Barker; Robert G Ojemann; Victor-Felix Mautner; Mia MacCollin
Journal:  J Neurosurg       Date:  2006-02       Impact factor: 5.115

3.  Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.

Authors:  A Mohyuddin; W J Neary; A Wallace; C L Wu; S Purcell; H Reid; R T Ramsden; A Read; G Black; D G R Evans
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

4.  Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification.

Authors:  D Gareth R Evans; R T Ramsden; A Shenton; C Gokhale; N L Bowers; S M Huson; G Pichert; A Wallace
Journal:  J Med Genet       Date:  2007-02-16       Impact factor: 6.318

Review 5.  Neurofibromatosis 2.

Authors:  Michael Hoa; William H Slattery
Journal:  Otolaryngol Clin North Am       Date:  2012-04       Impact factor: 3.346

Review 6.  The neurofibromatoses.

Authors:  Rosalie E Ferner
Journal:  Pract Neurol       Date:  2010-04

7.  Interdomain binding mediates tumor growth suppression by the NF2 gene product.

Authors:  L Sherman; H M Xu; R T Geist; S Saporito-Irwin; N Howells; H Ponta; P Herrlich; D H Gutmann
Journal:  Oncogene       Date:  1997-11-13       Impact factor: 9.867

8.  Malignant schwannoma in siblings with neurofibromatosis.

Authors:  A K Sayed; B Bernhardt; A R Perez-Atayde; R M Bannerman
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

9.  Exon scanning for mutation of the NF2 gene in schwannomas.

Authors:  L B Jacoby; M MacCollin; D N Louis; T Mohney; M P Rubio; K Pulaski; J A Trofatter; N Kley; B Seizinger; V Ramesh
Journal:  Hum Mol Genet       Date:  1994-03       Impact factor: 6.150

Review 10.  Neurofibromatosis type 1 revisited.

Authors:  Virginia C Williams; John Lucas; Michael A Babcock; David H Gutmann; Bruce Korf; Bernard L Maria
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.